NEVIRAPINE APOTEX nevirapine 200 mg tablet blister pack

Active ingredient:

nevirapine, Quantity: 200 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Nevirapine

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: magnesium stearate; lactose; microcrystalline cellulose; crospovidone; copovidone

Administration route:

Oral

Units in package:

60

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Nevirapine immediate-release tablets in combination with antiretroviral agents are indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Product summary:

Visual Identification: white, oval shaped scored biconvex tablets with engraved "APO" and bisect on one side and "NAV" bisect "200" on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2016-03-17